Tyche Industries Ltd
TYCHEBSE
₹102.95▼ -3.00 (-2.83%)
Whole company worth₹106 Cr
Price for ₹1 of profit₹15
1-year range₹99 – ₹148
The short version
A shrinking, thinly profitable business — priced in line with what it earns.
What Tyche does
Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients
Worked out from Tyche's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Tyche is a micro-sized company in pharmaceuticals.
Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients
- Whole company is worth
- ₹106 crore
- Run by
- SANDEEP GOKARAJU
- Shareholders
- 6,786 people
- Listed since
- 2000
A very small company by stock-market value — prices can swing hard and trading can be thin.
02Is it growing?
Sales have shrunk 7% a year for 5 years.
Profit, though, fell 19% a year over the same stretch.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹13 as profit.
Here is where the money from Tyche's sales went in FY26, the latest full year it has reported.
₹45
₹34
₹13
- ₹45Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹34Running the businessstaff, rent, marketing, power and everything else
- ₹3.7Wear and tearmachines, stores and buildings losing value over time
- ₹4.7Taxincome tax paid to the government
- ₹13Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹5 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹5
₹-10₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Under ₹12 is a thin return for the risk of owning shares. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹60 actually came in as cash.
Profit it reported₹32 Cr
Cash its business brought in₹19 Cr
Over the last 3 years: ₹32 crore of profit but ₹19 crore of cash. Some of the profit is tied up — often in unsold stock or money customers still owe.
04Is the price high or low?
You pay ₹15 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 15 means buyers are paying for about 15 years of today's profit up front.
The share price over the past year
It is 30% below its highest price of the past year and 4% above its lowest.
05Who owns it?
Its founders and parent group own 62 of every 100 shares — they control the company.
If the company were split into 100 equal shares, this is who would hold them. 6,786 people and institutions hold its shares.
As filed for the quarter ending 30 Jun 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
Two things going well, three things worth watching.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
- Has almost no debt — it is not at the mercy of lenders.
- Pays a dividend of about 3.1% of its share price each year.
Worth watching
- Sales fell 18% in the latest financial year.
- Sales have been shrinking — 7% a year.
- Thinly traded — only about ₹8 lakh of shares change hands a day, so buying or selling can move the price.
07What happened lately?
Latest quarter: sales down 28%, a loss.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹9.1 Cr
▼ 28.3% on a year earlier
Loss
₹0.0 Cr
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Tyche?
This page describes Tyche using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Tyche Industries Ltd (TYCHE): company summary
The company's annual revenue fell 18.1% to ₹54 crore, while annual net profit dropped 44.4% to ₹7 crore.
Tyche Industries Ltd (TYCHE) is a micro-cap Healthcare company valued at ₹106 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Tyche Industries Ltd last traded at ₹102.95, down 2.83% on the day.
- Recent developments
- On 2026-09-23, the company announced a dividend of ₹3.50 per share, ex-date. In the latest quarter, the company reported a net profit loss of ₹0 crore, reversing a net profit of ₹2 crore in the same quarter a year earlier.
- Financial performance
- The company's annual revenue fell 18.1% to ₹54 crore, while annual net profit dropped 44.4% to ₹7 crore. The latest quarter saw revenue fall 28.3% to ₹9 crore, swinging from a net profit of ₹2 crore to a loss of ₹0 crore.
- Valuation multiples
- The stock trades at 15.4 times earnings, a discount to the Healthcare median of 32.0, 0.82 times book value. It yields 3.1%.
- Things to watch
- The company's net profit margin narrowed 6.1 percentage points to 12.9%. The latest quarter net profit swung from a net profit of ₹2 crore to a loss of ₹0 crore. The stock is 28.4% below its 52-week high.
- Where it stands
- The company's latest quarter net profit swung from a net profit of ₹2 crore to a loss of ₹0 crore. The stock is 28.4% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Healthcare stocks · Pharmaceuticals
Explore Tyche Industries Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Tyche Industries Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Tyche Industries Ltd with peers
Tyche Industries Ltd vs Sun Pharmaceutical Industries LimitedTyche Industries Ltd vs Divi's Laboratories LimitedTyche Industries Ltd vs Torrent Pharmaceuticals LimitedTyche Industries Ltd vs Laurus Labs LimitedTyche Industries Ltd vs Zydus Lifesciences LimitedTyche Industries Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Tyche Industries Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing